TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/03/2024
Back to search
Official data from USPTO
ARGENX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
09/07/2024
Trademark type
Combined
Nice classes
5, 35, 42, 44
Filing date
12/21/2022
Registration date
09/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/03/2024
Last transaction
09/07/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Zwijnaarde, BE
Examiner
KNIGHT, TROY FRANK
Law office
L70
Current location
PETITIONS OFFICE
Mark description
The mark consists of the word "ARGENX" in lowercase in dark gray followed by a V-shaped design, the left segment in dark green and the right segment in green, positioned above a circle in green.
Holders and representatives
Holders
argenx B.V.
Representatives
Edward T. White Williams Mullen
Technical classification
Nice Classes
Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmuneantibody-mediatedneuromuscularhematologicalinflammatoryrespiratorykidneyskintransplantation-related diseases and disorderscancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmuneantibody-mediatedneuromuscularhematologicalinflammatoryrespiratorykidneyskintransplantation-related diseases and disorderscancer and diseases of the immune system
Class 35
Wholesale and retail store services for pharmaceutical preparations in the field of immunology and autoimmune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; marketing services and patient information services namelyproviding consumer product information in the field of immunologydiseases of the immune system and antibody therapeutics; provision of customer or patient informationproviding consumer product information relating to pharmaceuticalmedicalhealthcare products through an online computer network; administration of patient reimbursement programs
Class 42
Research and development in the field of immunologyantibody engineering and autoimmune diseases; drug research and development in the field of immunologyantibody technology and autoimmune diseases; scientific and technological servicesresearchdesignanalysistesting in the field of immunityautoimmune diseases and antibody engineering; providing medical and scientific research information in the field of pharmaceuticalsclinical trialsresearch and development
Class 44
Providing information to patients in the field of auto-immuneantibody-mediatedneuromuscularhematologicalinflammatoryrespiratorykidneyskintransplantation-related diseases and disorderscancer and diseases of the immune system and the treatment thereof; medical consultancy and medical information services relating to biopharmaceutical products
Publications
History of USPTO decisions and trademark events.
35 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/03/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
09/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/03/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/03/2024
CHPB
POST PUBLICATION AMENDMENT - ENTERED
07/12/2024
APET
ASSIGNED TO PETITION STAFF
07/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/18/2024
PUBO
PUBLISHED FOR OPPOSITION
06/18/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
06/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/29/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/16/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/16/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
05/15/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
05/15/2024
CNSI
SUSPENSION INQUIRY WRITTEN
05/15/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/24/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/22/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/19/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/19/2023
GNSL
LETTER OF SUSPENSION E-MAILED
10/19/2023
CNSL
SUSPENSION LETTER WRITTEN
10/19/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/14/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/14/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/14/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/06/2023
GNRT
NON-FINAL ACTION E-MAILED
06/06/2023
CNRT
NON-FINAL ACTION WRITTEN
06/06/2023
DOCK
ASSIGNED TO EXAMINER
05/04/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/19/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/18/2023
NWAP
NEW APPLICATION ENTERED
12/24/2022
Continuous trademark protection
Get notified about every new filing that threatens ARGENX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.